Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Guess they didn't sign all those NDA that longs claim everyone in the world has signed to keep this powerful placebo cure under wraps.
I'm imaging what excuses will happen in 2024. LP's Amish nephew has Rumspringa so they can't submit the application to the MHRA.
The goal of any article by renowned oncologists is to move potential treatments forward and discuss trial failures, and at this point, NWBO is a failure yet LP is quite rich from selling BS (and CDMOs and shares).
NWBO certainly doesn't want a public debate or literally every oncologist not involved in the trial will easily shred any of Liau's poor arguments by simply pointing to FDA guidance, proper trial design, and standard trial reporting, including scheduling an IA in the protocol, performing the IA, and following DSMB guidance.
But first they will all laugh at the Swiss approval as precedents that LP is a sheister.
You’ve been a little turd on the board for quite some time. The only people “working overtime “ should be the pieces of crap
Paid by the shareholders who have failed to move this overpriced placebo forward.
But it’s holiday season and GBM patients don’t die over the holidays so everyone at NWBO and the publishers will see you in 2024 after vacation!
Now do the 50 lies from Linda Liau regarding the horseshit P3.
Chiocca has more than twice the publications
of Linda Liau
And flipper just gets thumbs up for his breadcrumb shilling.
It’s time to trash your own poor stock picking advice and not published oncologists who realize this trial is a shit show.
You wouldn’ need BS conspiracy theories against published oncologists (unlike 90% of the idiots credited in the JAMA trash). If said JAMA data didn’t suck to everyone except
Company shills.
Happy holidays.
It’s time you apologize to those oncologists you’ve attacked constantly. Attack Liau for giving false hope to GBM patients by continuing the charade of DCVax when the data clearly shows it doesn’t do anything.
Zero reason to retract an article. Only an idiot would think an article would be retracted and not a simple footnote or amendment be added instead.
NWBO hasn’t retracted the garbage JAMA article despite numerous renowned oncologists questioning numerous problems with it.
The actual number of specials happened to specials. Negligible at best. There are enough actual oncologists with more experience running clinical trials with legit companies that have questioned the P3 and the company that those asked to give money on a Gofundmes can Google and and see the treatment doesn’t do anything.
Why would they retract all the valid reasons the trial changes, design, data, and ECA suck?
I would not support a scam stock run by charlatans ripping off people dealing with a serious disease.
Danish Dunce regurgitates the same page others have used trying to show DCVax does something and even the author of the page has had multiple different treatments and multiple surgeries.
Let’s see a Gotundme for DCVax from 5 years ago where the patient is still alive.
Neither one has ever brought a drug through the approval process. Moot point as they both know this won’t be approved on the messed up P3.
Management would have to address the 100 other problems with the trial. LL tried and simply proved this trial is essentially exploratory because they effed it up so bad.
Why would they retract the paper? They correct the one issue and keep the many others showing the trial sucked.
No person not involved with the company who has actually read the JAMA article has written a positive piece on the data. Anyone with an over 80 IQ (ie, not Bala) can point out 20 issues with the design, data, changes post hoc, ECA, etc.
They trot out the same 3-5 patients, all who have had multiple treatments, most who have had multiple surgeries.
OMG, most of the authors have been published articles regarding GBM more than all on the JAMA paper combined.
Keep character assassinating. Typical.
It’s in his pay structure. Saying nothing makes him nothing.
Shills here are as altruistic as LP is.
Or LP pay 5% of what she milked out of shareholders and patients who had to start gofundmes to pay for a piece of crap placebo like DCvax. And she could donate it to hospices that actually help cancer patients.
Nobody on Wall Street expects a publicly traded company to PR 10 times why they are idiots and can’t submit a BLA or the MHRA equivalent and who they are blaming.
Now post 100 more walls of useless text and get a few attaboys from the others on the shill team.
“The question is not who MADE money on Cognate and Advent but WHO will benefit from them.”
Answer: Linda Powers, whether the company submits anything or not.
Happy Thanksgiving to all those who have used 13 years of flipper breadcrumbs to make stuffing for their turkey.
Of course you do, shillster.
They understand how real trials are designed and run without changing everything post hoc. You should take note.
No surprise there. Shills be shillin’!
They “Sky is an idiot who only spams the board with copy and pasted BS” maneuver?
Keep shilling. It doesn’t matter what font you use or how many pretty pictures you spam. The company hasn’t submitted crap to anyone and has made 100 excuses. I wouldn’t submit either of I had such crap data unless I was trying to get DCvax approved as the newest placebo. But water is cheaper.
Not to mention they ripped off their only institutional investor Woodford.
He does as much as LP does.
Your employer is NWBO.
You should be asking questions of the company, shilly shillster. Not of others posting when you don’t even understand the topic.
Ex and I have posted valid issues with the poor data and scammy behavior of Lp and other employees who literally scammed shareholders into financing a CDMO that she sold for hundreds of millions of dollars. And she’s doing it again.
The data has zero chance of being approved by anyone. Having zero valid control arm is a problem as pointed out by many oncologists who question the trial and the data.
If the data was any good this company would have been offered a sum LP couldn’t have refused.
Counter? You spam the board with the same crap l, defending the scam company because they paid you to delete posts as moderator.
Quit lying.
This is the only publicly traded company that PRs "problems with publishers" so it's shills can point to "progress". The PR points to the 100th excuse of a scam, not progress.